Antibody drug development in china
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Poster
- By: FANG, Jianmin (Tongji University, Shanghai, China)
Antibody drugs represent one of the fastest growing areas in pharmaceutical industry. As the most populous country with increasingly aging population and changing life style, China has a large demand for high quality monoclonal antibody drugs to treat various diseases. In the past decade, a large number of biotech/biopharmaceutical companies have.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.